1. Home
  2. DNA vs CRESY Comparison

DNA vs CRESY Comparison

Compare DNA & CRESY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNA
  • CRESY
  • Stock Information
  • Founded
  • DNA 2008
  • CRESY 1936
  • Country
  • DNA United States
  • CRESY Argentina
  • Employees
  • DNA N/A
  • CRESY N/A
  • Industry
  • DNA Biotechnology: Biological Products (No Diagnostic Substances)
  • CRESY Real Estate
  • Sector
  • DNA Health Care
  • CRESY Finance
  • Exchange
  • DNA Nasdaq
  • CRESY Nasdaq
  • Market Cap
  • DNA 658.5M
  • CRESY 664.8M
  • IPO Year
  • DNA N/A
  • CRESY 1997
  • Fundamental
  • Price
  • DNA $9.42
  • CRESY $10.82
  • Analyst Decision
  • DNA Sell
  • CRESY
  • Analyst Count
  • DNA 3
  • CRESY 0
  • Target Price
  • DNA $9.67
  • CRESY N/A
  • AVG Volume (30 Days)
  • DNA 1.6M
  • CRESY 187.8K
  • Earning Date
  • DNA 08-07-2025
  • CRESY 09-08-2025
  • Dividend Yield
  • DNA N/A
  • CRESY 5.53%
  • EPS Growth
  • DNA N/A
  • CRESY N/A
  • EPS
  • DNA N/A
  • CRESY 0.09
  • Revenue
  • DNA $237,417,000.00
  • CRESY $648,198,954.00
  • Revenue This Year
  • DNA N/A
  • CRESY N/A
  • Revenue Next Year
  • DNA $15.91
  • CRESY N/A
  • P/E Ratio
  • DNA N/A
  • CRESY $10.63
  • Revenue Growth
  • DNA 13.76
  • CRESY N/A
  • 52 Week Low
  • DNA $5.00
  • CRESY $6.56
  • 52 Week High
  • DNA $16.85
  • CRESY $14.23
  • Technical
  • Relative Strength Index (RSI)
  • DNA 51.44
  • CRESY 40.37
  • Support Level
  • DNA $9.75
  • CRESY $10.60
  • Resistance Level
  • DNA $13.33
  • CRESY $11.07
  • Average True Range (ATR)
  • DNA 0.87
  • CRESY 0.31
  • MACD
  • DNA -0.18
  • CRESY 0.00
  • Stochastic Oscillator
  • DNA 28.59
  • CRESY 9.46

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

About CRESY Cresud S.A.C.I.F. y A.

Cresud SACIF y A is engaged in agricultural business and urban properties and investment business. Under its agricultural business the company produces oilseed grains and cereals, sugar cane and meat. The Agricultural business of the company is further comprised of four reportable segments which are Agricultural production, Land transformation and Sales, Corporate and Other segments. The company participates in the real estate business in Argentina through its subsidiary IRSA. The real estate business is further comprised of five reportable segments, namely Shopping Malls, Offices, Sales and Developments, Hotels and others.

Share on Social Networks: